ConvEyXO, founded in 2019 by veterans of pharma industry, builds a specialized technology platform to convey exosome-based therapeutics to the market. The company is developing is therapeutic portfolio in the field of fibrosis and chronic inflammatory disorders. The rapid development of the company is the result of collaborations with partners with a demonstrated track record in healthtech and biotech fields.
External link for convEyXO
Brussels South Charleroi BioPark
Gosselies, 6041, BE
Gaston Geenslaan 1
Leuven, 3001, BE
Looking forward to joining #ISEV2025 in Austria and participating in fruitful discsssions for EV therapeutic development.
🤩 Abstract submission and early registration for the #ISEV2025 Annual Meeting are now open! 🎼 Submit your abstracts before November 3rd: https://buff.ly/4e8W0Xu Eva Rohde, Eva-Maria Krämer-Albers, An Hendrix, Andreas Möller, Bo Li (李博), Edit Buzás, Johannes Grillari, Lucia Languino, Mario Gimona, Sun Young Lee, Wolfgang Holnthoner
Let’s gear up small EVs loaded to the next level ! #extracellular_vesicles #technology_platform #anti_inflamm_aging
Congratulations to convEyXO on being the latest addition to the "Global Database of Exosome Companies, 2024": https://lnkd.in/g8VVNaHr ConvEyXO, a Belgian biotech company, targets inflammatory and degenerative diseases with unmet medical needs by reducing inflammation and repairing tissue damages from cellular senescence with its Therapeutic Platform based on small Extracellular Vesicles (sEV or exosomes) secreted by Mesenchymal Stem Cells (MSCs), with their intrinsic immuno-modulatory and regenerative properties, amplified by loaded miRNA. ConvEyXO resolves sEV industrialization key challenges with a proprietary Technology Platform, making their therapies triple A with (1) homogenous industrial manufacturing from single cell line sourcing, with robust isolation, purification and characterization processes, (2) cost-efficient scalable production with patented process and proprietary 3D custom fixed-bed bioreactor and (3) Amplified sEV native properties by loading miRNA with a breakthrough microfluidic technology. #exosomes #extracellularvesicles #advancedtherapies Frédéric Tonglet
We're looking for our new colleague to join our operation team as Senior Cell Culture Technician at convEyXO! Want to make an impact in the life sciences sector? Would you like to join a fast-growing start-up? Would you like to share your professional enthusiasm in a dynamic environment? Then come and join us! 🚀 hashtag #exosomes hashtag #cell_culture hashtag #Technician convEyXO Cap4HR Brussels South Charleroi BioPark
🚨 Job Alert!🚨 Join convEyXO as their new Senior Cell Culture #Technician! Come and join their Operations team and be part of something amazing 🚀 Apply now and help shape the future of life sciences! avec Frédéric Tonglet, Valérie Roels et Marie Coulon #Hiring #LifeSciences #cellculture #JobOpportunity #Biotech #CareerOpportunity
We're looking for our new colleague to join our operation team as Senior Cell Culture Technician at convEyXO! Want to make an impact in the life sciences sector? Would you like to join a fast-growing start-up? Would you like to share your professional enthusiasm in a dynamic environment? Then come and join us! 🚀 #exosomes #cell_culture #Technician convEyXO Cap4HR Brussels South Charleroi BioPark
convEyXO reposted this
📢CALL FOR APPLICATION OF ASSOCIATE EDITORS 📢 Both of our Journals are currently looking to expand their Editorial Board and are calling for applications for the role of Associate Editor. The Journal of Extracellular Vesicles (JEV) provides a much-needed forum for the exchange of data, ideas and information from all areas pertaining to the chemistry, biology and/or applications of extracellular vesicles, including microvesicles, exosomes, ectosomes, apoptotic bodies and other extracellular vesicles. The Journal of Extracellular Biology provides broader publication opportunities for research on extracellular vesicles, extracellular particles, and how they interact with each other, with other extracellular macromolecules, and with the extracellular matrix, cells, and organs. Journal of Extracellular Biology is now indexed on PubMed Central. For the Journal of Extracellular Biology we are particularly keen to see applications from those with experience in extracellular macromolecules and the extracellular matrix to represent the broad scope of the journal. To find out more, and to apply, visit https://lnkd.in/eBaPP-fw #extracellularvesicles #extracellularmatrix #ecm #EVs #extracellularbiology #extracellularmacromolecules
Great collaboration for cutting-edge technologies IPRATECH @exo-harvest Frédéric Tonglet Jean-Paul Prieels Jean SMAL David Sergeant Sambrinvest Brussels South Charleroi BioPark
BioInformant.com, World's Largest Publisher of Stem Cell News | Real Estate Investor | PatriotHoldings.com, Board Member, & Advisor | Former USA Rugby Player
EXO-Harvest to launch breakthrough scalable fixed-bed bioreactor platform for MSC and EVs manufacturing - https://lnkd.in/gc5cKeQ6 EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH. The platform is now fully operational, marking a significant milestone in joint efforts to advance biotechnological solutions through engineering excellence. EXO-Harvest’s launch of the breakthrough multi-scale bioreactor platform will help overcome the challenges of MSC and EV manufacturing, to make therapies “triple A” from day one —Available, Accessible, and Affordable. EXO-Harvest created 2 versions: a small-scale multi-bioreactor for process development and a mid/large scale bioreactor for clinical lot production. The small scale multi-parallel screening platform offers a cost-efficient way for process development of cells and EVs production from small to mid-scales for full industrialization. The automated and integrated system enables rapid optimization of all critical parameters such as culture media and refreshment strategies, fixed beds and their geometries, fluidics and kinetics, among others. ConvEyXO successfully integrated this innovative multi-scale bioreactor platform, utilizing EXO-Harvest as an enabler to progress, in a cost-efficient way, towards clinical product development and industrialization. With EXO-Harvest’s multi-scale bioreactor platform as an enabler, convEyXO advances its anti inflamm-aging therapeutic product development reducing the cost and time, while optimizing the EV production of their WJ-iMSC’s and achieving a 1010 EV/cm2 of adherence with the custom fixed bed bioreactor. Based on convEyXO WJ-iMSC cell line and EXO-Harvest manufacturing capabilities, convEyXO can consider producing batches with unprecedented homogeneity and affordability. Read more at: https://lnkd.in/gc5cKeQ6 #exosomes #extracellularvesicles #advancedtherapies #bioreactor Borg Hemelaer Frédéric Tonglet
🚀 EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH. The platform is now fully operational, marking a significant milestone in joint efforts to advance biotechnological solutions through engineering excellence. 💡EXO-Harvest’s launch of the breakthrough multi-scale bioreactor platform will help overcome the challenges of MSC and EV manufacturing, to make therapies triple A from day one —available, accessible, and affordable. This innovative technology has been integrated by convEyXO into its anti inflamm-aging platform to successfully industrialize EVs manufacturing. 𝐀𝐛𝐨𝐮𝐭 𝐄𝐗𝐎-𝐇𝐚𝐫𝐯𝐞𝐬𝐭 EXO-HARVEST, an affiliate of ConvEyXO, is dedicated to developing technologies in the field of mesenchymal stem cells (MSCs) and extracellular vesicles (EVs). EXO-HARVEST has developed multi-scale bioreactor platform to industrialize the manufacturing of adherent cells and extracellular vesicles using 3D printed fixed beds. The platform offers scalability from screening - for process development in a cost-efficient way - up to industrialization. 𝐀𝐛𝐨𝐮𝐭 𝐜𝐨𝐧𝐯𝐄𝐲𝐗𝐎 ConvEyXO is committed to a healthier lifespan through the development of an anti inflamm-aging and anti-inflammatory therapeutic portfolio, addressing high-prevalence unmet medical needs by unlocking the transformative power of extracellular vesicles (EVs). By focusing on the industrialization of EV manufacturing using a 3D printed fixed bed, convEyXO aims to revolutionize this field. 𝐀𝐛𝐨𝐮𝐭 𝐈𝐏𝐑𝐀𝐓𝐄𝐂𝐇 IPRATECH is dedicated to advancing biotechnological solutions through engineering excellence. Thanks to IPRATECH's collaboration, we have successfully integrated the fixed bed in the manufacturing process, turning our vision into reality. 👏 Thank you, IPRATECH, for the exceptional collaboration. #exoharvest #exosome #conveyxo #ipratech #biotech #ESACT
Want to see a concrete case of Ipratech's custom development of bioreactor controllers. Come and say Hi at booth 47 of ESACT 2024 to discover the EXOHARVEST's exosome production from small to manufacturing scale! #exoharvest #exosome #ipratech #biotech
We are honored to have been able to share our experience and the added value of the Brussels South Charleroi BioPark community in the development of convEyXO and its subsidiaries. #BioPark Champions League
✨ À l'initiative de la Belgian Presidency of the Council of the European Union 2024, nous avons accueilli des représentants de l'Union Européenne en charge de la Politique de Cohésion au Brussels South Charleroi BioPark. Dans le cadre d'un programme intensif de 3 jours, visant à faire découvrir les projets financés par le Fonds social européen (FSE) et le Fonds européen de développement régional (FEDER) à Charleroi, la visite du BioPark Charleroi avait pour objectif de mettre en lumière les avancées et les innovations de notre écosystème. Une belle occasion de partager notre vision et nos ambitions avec des acteurs clés de l'Union Européenne et de renforcer nos collaborations. 🤝 Moments forts de cette journée : 🌟 Présentation du BioPark par Dominique Demonte, CEO du BioPark, et découverte du campus à travers trois visites immersives : 🔬 Institut de Pathologie et de Génétique - Seqalis : Plongée dans un projet innovant de biotechnologies appliquées, illustrant le potentiel de la recherche et du développement au BioPark Charleroi. 🔍 CMMI - Centre de microscopie et d'imagerie moléculaire : Découverte de ce centre de pointe, essentiel pour les avancées en pré-imagerie clinique et la contribution du BioPark Charleroi à la médecine de précision. 🚀 Biotech 4 - Incubateur et Labhotel : Visite de l'incubateur 4 qui accompagne des startups et projets prometteurs dans le secteur des biotechnologies. Rencontre avec deux sociétés locataires au Biotech 4 : Stellaris Therapeutics et convEyXO. Un grand merci à tous les participants, intervenants et organisateurs, en particulier à la Présidence belge du Conseil de l'Union européenne pour son initiative et son soutien. 👏 El Taghdouini Adil Frédéric Tonglet Hélène De Reytere Robert MULLER David Pérez-Morga Jeremie Gras #Biotech #Medtech #BioParkCharleroi 📸 Crédit photo : Elodie Meunier - Wallonie-Bruxelles International (WBI)
Experienced and trusted partner to take biotech processes to the next technology level ! Their unique engineering experience and smart approach has enabled convEyXO to develop a ground-breaking bioreactor platform, which we are thrilled to unveil at ESACT - European Society for Animal Cell Technology Stay tuned! Go IPRATECH #ExtracellularVesicles #Innovation #Agility #industrialization #PushBoundaries #EXO-Harvest convEyXO Brussels South Charleroi BioPark Sambrinvest
🔬 IPRATECH at ESACT 2024! We're delighted to announce our participation at ESACT 2024, from June 23 to 26 in Edinburgh. Visit us on stand 48 to discover our latest innovations in biotechnology! 🎥 Watch our video for a taste of what's in store: 1️⃣ Cytosys: Discover our Control Platform for Advanced Cell Culture Process, designed to revolutionize your cell culture operations. 2️⃣ What's new: Don't miss the presentation of our innovative solutions that push the boundaries of biotechnology technology. 🔹 Why visit us? Cytosys: Learn how our advanced control platform can transform your cell culture processes by increasing efficiency and precision. Expertise and Innovation: Discuss cell culture challenges with our experts and discover solutions that enhance your research. New developments: Be the first to discover our latest technologies and how they can boost your projects. 📅 Dates: June 23-26, 2024 📍 Location: Edinburgh, Scotland 🔢 Stand: 48 Come and explore the future of cell culture with us. We look forward to meeting you and sharing our advances with you! #ESACT2024 #Biotechnology #CellCulture #Innovation #IPRATECH #Cytosys #AdvancedProcess #Technology